Indium-111 pentetreotide single-photon emission tomography in patients with TSH-secreting pituitary adenomas: Correlation with the effect of a single administration of octreotide on serum TSH levels
- 1 July 1997
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 24 (7) , 728-731
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Somatostatin receptor scintigraphy: Its value in tumor localization in patients with cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretionThe American Journal of Medicine, 1994
- Effects of a slow‐release formulation of the new somatostatin analogue lanreotide in TSH‐secreting pituitary adenomasClinical Endocrinology, 1994
- Octreotide Therapy for Thyroid-Stimulating Hormone-Secreting Pituitary Adenomas: A Follow-up of 52 PatientsAnnals of Internal Medicine, 1993
- Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.The Journal of Clinical Endocrinology & Metabolism, 1992
- The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of TumorsEndocrine Reviews, 1991
- Somatostatin-Receptor Imaging in the Localization of Endocrine TumorsNew England Journal of Medicine, 1990
- Surgical treatment of thyrotropin-secreting pituitary adenomasJournal of Neurosurgery, 1990
- Thyrotropin-Secreting Pituitary Adenomas: Clinical and Biochemical HeterogeneityAnnals of Internal Medicine, 1989
- Response of Thyrotropin-Secreting Pituitary Adenomas to a Long-Acting Somatostatin AnalogueNew England Journal of Medicine, 1987
- Inappropriate Secretion of Thyrotropin by the PituitaryHormone Research, 1987